The value of Fludarabine in addition to ARA-C and G-CSF in the treatment of patients with high risk myelodysplastic syndromes and elderly AML

G.J. Ossenkoppele; W.J. Graveland; P. Sonneveld; S.M. Daenen; D.H. Biesma; L.F. Verdonck; M.R. Schaafsma; P.H. Westveer; G.J. Peters; P. Noordhuis; P. Muus; B. van der Holt; M. Delforge; B. Lowenberg; G.E. Verhoef

doi:10.1182/blood-2003-07-2195

The value of Fludarabine in addition to ARA-C and G-CSF in the treatment of patients with high risk myelodysplastic syndromes and elderly AML

Translated title of the contribution: The value of Fludarabine in addition to ARA-C and G-CSF in the treatment of patients with high risk myelodysplastic syndromes and elderly AML

G.J. Ossenkoppele, W.J. Graveland, P. Sonneveld, S.M. Daenen, D.H. Biesma, L.F. Verdonck, M.R. Schaafsma, P.H. Westveer, G.J. Peters, P. Noordhuis, P. Muus, B. van der Holt, M. Delforge, B. Lowenberg, G.E. Verhoef

Hematology/Van Creveldclinic

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	The value of Fludarabine in addition to ARA-C and G-CSF in the treatment of patients with high risk myelodysplastic syndromes and elderly AML
Original language	Undefined/Unknown
Pages (from-to)	2908-2913
Number of pages	6
Journal	Blood
Volume	103
Issue number	8
DOIs	https://doi.org/10.1182/blood-2003-07-2195
Publication status	Published - 2004

Access to Document

10.1182/blood-2003-07-2195

Cite this

Ossenkoppele, G. J., Graveland, W. J., Sonneveld, P., Daenen, S. M., Biesma, D. H., Verdonck, L. F., Schaafsma, M. R., Westveer, P. H., Peters, G. J., Noordhuis, P., Muus, P., van der Holt, B., Delforge, M., Lowenberg, B., & Verhoef, G. E. (2004). The value of Fludarabine in addition to ARA-C and G-CSF in the treatment of patients with high risk myelodysplastic syndromes and elderly AML. Blood, 103(8), 2908-2913. https://doi.org/10.1182/blood-2003-07-2195

@article{bb1f1bf6c0e14528a1c4e158f48085da,

title = "The value of Fludarabine in addition to ARA-C and G-CSF in the treatment of patients with high risk myelodysplastic syndromes and elderly AML",

author = "G.J. Ossenkoppele and W.J. Graveland and P. Sonneveld and S.M. Daenen and D.H. Biesma and L.F. Verdonck and M.R. Schaafsma and P.H. Westveer and G.J. Peters and P. Noordhuis and P. Muus and {van der Holt}, B. and M. Delforge and B. Lowenberg and G.E. Verhoef",

year = "2004",

doi = "10.1182/blood-2003-07-2195",

language = "Undefined/Unknown",

volume = "103",

pages = "2908--2913",

journal = "Blood",

issn = "0006-4971",

publisher = "American Society of Hematology",

number = "8",

}

Ossenkoppele, GJ, Graveland, WJ, Sonneveld, P, Daenen, SM, Biesma, DH, Verdonck, LF, Schaafsma, MR, Westveer, PH, Peters, GJ, Noordhuis, P, Muus, P, van der Holt, B, Delforge, M, Lowenberg, B & Verhoef, GE 2004, 'The value of Fludarabine in addition to ARA-C and G-CSF in the treatment of patients with high risk myelodysplastic syndromes and elderly AML', Blood, vol. 103, no. 8, pp. 2908-2913. https://doi.org/10.1182/blood-2003-07-2195

TY - JOUR

T1 - The value of Fludarabine in addition to ARA-C and G-CSF in the treatment of patients with high risk myelodysplastic syndromes and elderly AML

AU - Ossenkoppele, G.J.

AU - Graveland, W.J.

AU - Sonneveld, P.

AU - Daenen, S.M.

AU - Biesma, D.H.

AU - Verdonck, L.F.

AU - Schaafsma, M.R.

AU - Westveer, P.H.

AU - Peters, G.J.

AU - Noordhuis, P.

AU - Muus, P.

AU - van der Holt, B.

AU - Delforge, M.

AU - Lowenberg, B.

AU - Verhoef, G.E.

PY - 2004

Y1 - 2004

U2 - 10.1182/blood-2003-07-2195

DO - 10.1182/blood-2003-07-2195

M3 - Article

C2 - 15070662

SN - 0006-4971

VL - 103

SP - 2908

EP - 2913

JO - Blood

JF - Blood

IS - 8

ER -